Showing 55 results

Archival description

UoA 5

Print preview

[A] Award of EU-FP7 funding to Alkion BioPharma

[A] Global Bd surveillance and isolation

[A] Incorporation on Neuroprotexeon Limited

[A] Structural bioinformatics virtual training course

[B] Elixir-UK node serives

[B] Environmental Impact Assessment for expanding Congonhas Airport

[B] Neuroprotexeon partnerships

[B] New Sahonagasy Action Plan 2016-2020

[C] Environmental Impact Assessment for landfill expansion

[C] Industry press release on sale of Alkion Biopharma to Evonik

[C] Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product

[C] Phyre identified as a resource on ExPASy

[C] The pathogenic fungi Batrachochytrium dendrobatidis and Batrachochytrium salamandrivorans and risk of negative impact on biodiversity

[D] Environmental Impact Assessment for housing development

[D] European Distribution Partnership between NeuroproteXeon and Linde

[D] Evonik press release on the acquisition of Alkion BioPharma

[D] Google Analytics

[D] Listing of Bsal at the OIE - World Organisation for Animal Health

Narrow your results by: